These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6619930)

  • 1. Presence of immunosuppressive factors in brain-tumor cyst fluid.
    Kikuchi K; Neuwelt EA
    J Neurosurg; 1983 Nov; 59(5):790-9. PubMed ID: 6619930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by phenytoin: implication for altered immune competence in brain-tumor patients.
    Kikuchi K; McCormick CI; Neuwelt EA
    J Neurosurg; 1984 Dec; 61(6):1085-90. PubMed ID: 6502237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproteins in human brain tumor cyst fluids.
    Murray KJ; Ausman JI; Chou SN; Douglas SD
    J Neurosurg; 1977 Mar; 46(3):314-9. PubMed ID: 557078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlation between serum immunosuppressive acidic protein and altered immunocompetence in patients with brain tumours.
    Kikuchi K; Gotoh H; Kowada M
    Acta Neurochir (Wien); 1990; 103(1-2):52-61. PubMed ID: 2360468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a local immune activation in cystic brain tumors.
    Boethius J; Lefvert AK; Sidén A
    J Neurosurg; 1990 Dec; 73(6):933-5. PubMed ID: 2230976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnostic value of immunoglobulin G in the cerebrospinal fluid of brain tumor patients, particularly in malignant tumors].
    Onodera Y; Saitoh Y; Nagai K
    Gan No Rinsho; 1987 Oct; 33(12):1402-6. PubMed ID: 3682191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses in patients with brain tumors. Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity.
    Neuwelt EA; Kikuchi K; Hill S; Lipsky P; Frenkel EP
    Cancer; 1983 Jan; 51(2):248-55. PubMed ID: 6821814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunochemical investigation of brain tumor cyst fluids (author's transl)].
    Kito K; Shimizu T; Kubota S; Yamazaki N; Takahashi K; Kitamura K
    No Shinkei Geka; 1979 Mar; 7(3):239-47. PubMed ID: 440523
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
    McVicar DW; Davis DF; Merchant RE
    J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
    Elliott LH; Brooks WH; Roszman TL
    J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
    Kuratsu J; Yoshizato K; Yoshimura T; Leonard EJ; Takeshima H; Ushio Y
    J Natl Cancer Inst; 1993 Nov; 85(22):1836-9. PubMed ID: 8230263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of normal brain-reactive antibodies in glioma cyst fluids.
    Brunet JM; Berger F; Gustin T; Lainé M; Benabid AL
    J Neuroimmunol; 1993 Aug; 47(1):63-72. PubMed ID: 8376549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor.
    Roszman TL; Brooks WH; Elliott LH
    J Neurosurg; 1987 Dec; 67(6):874-9. PubMed ID: 2824719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-group antigens and antibodies in human brain-tumor cysts.
    Murray KJ; Kay NE; Douglas SD
    J Neurosurg; 1978 Feb; 48(2):164-8. PubMed ID: 564396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen related to cell proliferation in malignant gliomas recognized by a human monoclonal antibody.
    Kokunai T; Tamaki N; Matsumoto S
    J Neurosurg; 1990 Dec; 73(6):901-8. PubMed ID: 2230972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive activity of bovine follicular fluid on bovine T lymphocytes in vitro.
    Fahmi HA; Hunter AG; Markham RJ; Seguin BE
    J Dairy Sci; 1985 Dec; 68(12):3312-7. PubMed ID: 3879256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen in patients with intracranial tumors.
    Suzuki Y; Tanaka R
    J Neurosurg; 1980 Sep; 53(3):355-60. PubMed ID: 7420150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors. Characterization of T helper and B cell function.
    Roszman TL; Brooks WH; Steele C; Elliott LH
    J Immunol; 1985 Mar; 134(3):1545-50. PubMed ID: 3155771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides.
    Edgington TS; Curtiss LK; Plow EF
    J Immunol; 1985 Jan; 134(1):471-7. PubMed ID: 3964817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
    Brooks WH; Netsky MG; Normansell DE; Horwitz DA
    J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.